TUMOR-SUPPRESSIVE FUNCTION OF MUTATED GELSOLIN IN RAS-TRANSFORMED CELLS

Citation
L. Mullauer et al., TUMOR-SUPPRESSIVE FUNCTION OF MUTATED GELSOLIN IN RAS-TRANSFORMED CELLS, Oncogene, 8(9), 1993, pp. 2531-2536
Citations number
32
Categorie Soggetti
Genetics & Heredity",Oncology
Journal title
ISSN journal
09509232
Volume
8
Issue
9
Year of publication
1993
Pages
2531 - 2536
Database
ISI
SICI code
0950-9232(1993)8:9<2531:TFOMGI>2.0.ZU;2-7
Abstract
The flat revertant R1, isolated from human activated Ha-ras oncogene-t ransformed NIH3T3 fibroblasts (EJ-NIH3T3), expresses a variant form of the actin-regulatory protein gelsolin (p92-5.7). We have cloned cDNAs encoding p92-5.7 and identified as the cause of the expression of p92 -5.7 a point mutation in codon 321, which results in an amino acid cha nge from proline to histidine. In order to understand the role of p92- 5.7 in reversion of ras-transformed cells, cDNAs encoding p92-5.7 or h uman authentic gelsolin as a control were transfected into EJ-NIH3T3 c ells. All the transfectants that produced p92-5.7 and one of three tra nsfectants that produced human authentic gelsolin either lost or reduc ed tumorigenicity in syngeneic mice. These results demonstrate that mu tated gelsolin can suppress a ras tumor and suggest that authentic gel solin, if expressed at increased levels, may have a similar suppressiv e potential. Our data propose an important role for gelsolin in cellla r signal transduction pathways that involve the mammalian ras proto-on cogene.